EUVIMEDEUVIMED entdecken
Crossref

Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19

Malignancy Spectrum · 2026 · 3 (1) · 35

DOI: 10.15302/msp.2026.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malignancy Spectrum, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19. Malignancy Spectrum, 3(1), 35. https://doi.org/10.15302/msp.2026.0002

Vancouver

Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19. Malignancy Spectrum. 2026;3(1):35. doi:10.15302/msp.2026.0002

BibTeX
@article{euvimed2026,
  title = {Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19},
  journal = {Malignancy Spectrum},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {35},
  doi = {10.15302/msp.2026.0002}
}
Kostenlos starten →